Software facilitates clinical trial design and monitoring.
Press Release Summary:
Responding to demand for successful and safe clinical trials, East® 5 delivers tools to guide trial sponsors through trial design options, including adaptive, group sequential, and fixed sample size clinical trials. Program offers single-look trial designs and simulations, as well as report-ready table for protocol review and study results submission. It is suited for biopharmaceutical companies, medical device firms, research centers, and international regulatory agencies.
Original Press Release:
Cytel Inc. Releases East® 5 Clinical Trial Design System
Major update to the most widely-used software for clinical trial design, simulation, and analysis speeds clinical trial planning and increases likelihood of successful trial outcomes
CAMBRIDGE, Mass., July 12 /-- Cytel Inc., a leading provider of innovative clinical trial design software and services, today announced the release of East(R) 5, a major advancement to Cytel's highly-validated clinical trial design and monitoring software system. Virtually every major biopharmaceutical company, leading medical device firms, research centers, and international regulatory agencies rely on East to efficiently design the trial with the best possible chance of success.
Responding to the demand for more successful and safer clinical trials, East 5 delivers a host of new tools to better guide trial sponsors through the myriad of trial design options including adaptive, group sequential and fixed sample size clinical trials.
Major advances in East 5 include:
-- expanded visualization tools for better understanding of trial design concepts amongst trial planners, clinical operations and regulators
-- new report-ready tables for protocol review and study results submission
-- better designs for trials using smaller sample sizes
-- more single-look trial designs and simulations
"The East 5 release is a milestone achievement for Cytel and a major benefit to the many trial planners around the world that rely on East's versatility and accuracy" said Cyrus Mehta, Cytel's President and Co-Founder. "The new features are a direct result of combining invaluable feedback from current East users with our own biostatistical research and software development efforts. Helping our customers design better, more successful trials faster is what East 5 is all about".
East 5 is testament to Cytel's continuing commitment to providing the novel statistical methods, software, and expert services proven to reduce development lead times and increase the success rates of even the most complex clinical trials.
Available immediately, East 5 upgrades are now shipping to East customers worldwide with current maintenance programs. To order or learn more about East 5 please visit: http://cytel.com/Products/East/Default.asp
About Cytel
Celebrating its 20th anniversary, Cytel Inc. is a leading provider of clinical trial consulting services, specialized statistical software, and outsourced clinical study reports for the biopharmaceutical, medical device, academic, and research institute markets. Cytel's validated trial designs reduce development lead time and costs while increasing the probability of clinical trial success. Cytel Inc. is headquartered in Cambridge, MA, with software development and outsourcing facilities in Philadelphia, PA and Pune, India.
CONTACT: Michael Weitz of Cytel Inc., +1-617-661-2011, mike@cytel.com
